William David Travis
William David Travis publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
- World rank
- #621 of 7,710,434 ranked researchers
- Rank in United States
- #289 of 1,627,098
- Works
- 1,058
- Citations
- 140k
- Citations per work
- 132.1
What does William David Travis research?
William David Travis's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences71968.0%
- Medicine71968.0%
- Everything else29027.4%
- Life Sciences494.6%
- 1Pulmonary and Respiratory Medicine41% of their works
- 2Oncology13% of their works
- 3Epidemiology5% of their works
- 4Surgery5% of their works
- 5Molecular Biology5% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Neuroendocrine Tumor Research Advances
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe William David Travis's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, CT Screening, Lung Cancer, ALK Inhibitors and EGFR Mutations.
- Radiomics
- Pancreatic Neuroendocrine Tumors
- Malignant Pleural Mesothelioma
- Pulmonary Sclerosing Hemangioma
- Idiopathic Pulmonary Fibrosis
- Small-Cell Lung Cancer
- EGFR Mutations
- Lung Cancer
- Immunotherapy
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- CT Screening
- ALK Inhibitors
- Genomic Profiles
- Fibrosis
- Pulmonary Alveolar Microlithiasis
- BAP1 mutations
- Neuroendocrine Tumors
- Medical Imaging
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy3942 topics
- Clinical Trials3902 topics
- Targeted Therapy3902 topics
- Immunotherapy2432 topics
- CT Screening2321 topic
- Lung Cancer2321 topic
- ALK Inhibitors2281 topic
- EGFR Mutations2281 topic
- Genomic Profiles1621 topic
- Small-Cell Lung Cancer1621 topic
- Fibrosis1171 topic
- Idiopathic Pulmonary Fibrosis1171 topic
- Pulmonary Alveolar Microlithiasis831 topic
- Pulmonary Sclerosing Hemangioma831 topic
- BAP1 mutations811 topic
- Malignant Pleural Mesothelioma811 topic
- Neuroendocrine Tumors741 topic
- Pancreatic Neuroendocrine Tumors741 topic
- Medical Imaging711 topic
- Radiomics711 topic
Where does William David Travis work?
William David Travis's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.
How many publications and citations does William David Travis have?
OpenAlex counts 1,058 works and 139,720 citations for William David Travis, an h-index of 176, ranking #621 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about William David Travis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.